X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
index medicus (13) 13
male (10) 10
pharmacokinetics (10) 10
adult (9) 9
female (9) 9
pharmacology & pharmacy (9) 9
hepatitis c virus (7) 7
pharmacology (7) 7
pharmacology/toxicology (7) 7
ribavirin (7) 7
hcv (6) 6
hepatitis (6) 6
middle aged (6) 6
paritaprevir (6) 6
ritonavir (6) 6
abt-450/r-ombitasvir (5) 5
antiviral agents - administration & dosage (5) 5
antiviral agents - pharmacokinetics (5) 5
drug interactions (5) 5
genotype & phenotype (5) 5
hepatitis c (5) 5
internal medicine (5) 5
ombitasvir (5) 5
anilides - administration & dosage (4) 4
anilides - pharmacokinetics (4) 4
bioavailability (4) 4
carbamates - administration & dosage (4) 4
carbamates - pharmacokinetics (4) 4
drug dosages (4) 4
drug therapy, combination (4) 4
drug-drug interactions (4) 4
hepatitis c, chronic - drug therapy (4) 4
human necessities (4) 4
hygiene (4) 4
infections (4) 4
macrocyclic compounds - administration & dosage (4) 4
macrocyclic compounds - pharmacokinetics (4) 4
medical or veterinary science (4) 4
medicine & public health (4) 4
microbiology (4) 4
preparations for medical, dental, or toilet purposes (4) 4
ritonavir - administration & dosage (4) 4
ritonavir - pharmacokinetics (4) 4
sulfonamides - pharmacokinetics (4) 4
trial (4) 4
uracil - analogs & derivatives (4) 4
uracil - pharmacokinetics (4) 4
young adult (4) 4
analysis (3) 3
antiviral agents (3) 3
bioequivalence (3) 3
biomedicine (3) 3
c virus-infection (3) 3
chemistry (3) 3
computer simulation (3) 3
dasabuvir (3) 3
dose-response relationship, drug (3) 3
double-blind method (3) 3
metallurgy (3) 3
organic chemistry (3) 3
patients (3) 3
peptides (3) 3
pharmacotherapy (3) 3
studies (3) 3
sulfonamides - administration & dosage (3) 3
uracil - administration & dosage (3) 3
abridged index medicus (2) 2
adolescent (2) 2
adults (2) 2
aged (2) 2
antiretroviral drugs (2) 2
antiviral agents - adverse effects (2) 2
antiviral agents - therapeutic use (2) 2
article (2) 2
care and treatment (2) 2
chlorides - analysis (2) 2
chronic hepatitis-c (2) 2
chronic kidney disease (2) 2
cirrhosis (2) 2
clinical trials (2) 2
cross-over studies (2) 2
cystic fibrosis (2) 2
cystic fibrosis - drug therapy (2) 2
cystic fibrosis - genetics (2) 2
cystic fibrosis transmembrane conductance regulator - genetics (2) 2
cystic fibrosis transmembrane conductance regulator - metabolism (2) 2
dosage and administration (2) 2
drug administration schedule (2) 2
drug monitoring - methods (2) 2
drug therapy (2) 2
exposure (2) 2
fda approval (2) 2
gastroenterology and hepatology (2) 2
genetic aspects (2) 2
healthy volunteers (2) 2
hepacivirus - drug effects (2) 2
hepatitis c, chronic - blood (2) 2
hepatitis c, chronic - virology (2) 2
hepatitis-c (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2010, Volume 363, Issue 21, pp. 1991 - 2003
Journal Article
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 11/2018, Volume 57, Issue 11, pp. 1407 - 1419
The clinical development program of the direct-acting antiviral (DAA) combination therapy of paritaprevir (coadministered with ritonavir) and ombitasvir, with... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | TRIAL | PLUS RIBAVIRIN | ABT-450/R-OMBITASVIR | TRANSPORTERS | PHARMACOLOGY & PHARMACY | HCV | JAPANESE PATIENTS | OMBITASVIR/PARITAPREVIR/R | Studies | Genotype & phenotype | Hepatitis | Ethnicity | Infections | Interferon | FDA approval | Drug therapy | Patients | Drug dosages
Journal Article
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 8/2018, Volume 57, Issue 8, pp. 901 - 909
Investigating the effect of food on bioavailability during the development of an oral drug product is of prime importance because it has major implications on... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | PHARMACOLOGY & PHARMACY | BIOEQUIVALENCE | ABSORPTION | PHARMACOKINETICS | PRODUCTS | BIOAVAILABILITY | Studies | Medical equipment | Meals | Pharmaceuticals
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2018, Volume 13, Issue 5, p. e0198296
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2016, p. AAC.02135-16
Background: The three-direct acting antiviral (3D) regimen containing ombitasvir, paritaprevir, ritonavir and dasabuvir ± ribavirin (RBV) is approved for... 
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2016, Volume 60, Issue 1, pp. 105 - 114
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2017, Volume 61, Issue 2
The three-direct-acting antiviral (3D) regimen containing ombitasvir, paritaprevir, ritonavir, and dasabuvir with or without ribavirin (RBV) is approved for... 
Ombitasvir | Darunavir | HIV | DAA | HCV | Paritaprevir | Dasabuvir | EFFICACY | ombitasvir | SAFETY | MICROBIOLOGY | OPEN-LABEL | paritaprevir | PHARMACOLOGY & PHARMACY | darunavir | AGENTS | PARITAPREVIR/RITONAVIR | dasabuvir | Anilides - therapeutic use | Darunavir - pharmacokinetics | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Hepatitis C - metabolism | Coinfection - drug therapy | Humans | Middle Aged | Male | Anilides - pharmacokinetics | Carbamates - administration & dosage | Carbamates - pharmacokinetics | Uracil - administration & dosage | Darunavir - administration & dosage | Ritonavir - therapeutic use | Adult | Female | Drug Administration Schedule | Ritonavir - administration & dosage | Antiviral Agents - therapeutic use | Macrocyclic Compounds - pharmacokinetics | Uracil - therapeutic use | Coinfection - metabolism | Antiviral Agents - administration & dosage | Sulfonamides - pharmacokinetics | Macrocyclic Compounds - therapeutic use | Ritonavir - pharmacokinetics | Anilides - administration & dosage | Sulfonamides - therapeutic use | HIV Infections - drug therapy | Aged | Macrocyclic Compounds - administration & dosage | Carbamates - therapeutic use | Uracil - pharmacokinetics | Darunavir - therapeutic use | Sulfonamides - administration & dosage | HIV Infections - metabolism | Uracil - analogs & derivatives
Journal Article
Journal of Cystic Fibrosis, ISSN 1569-1993, 2013, Volume 13, Issue 2, pp. 139 - 147
Journal Article